Соединенные Штаты - английский - NLM (National Library of Medicine)

shiseido america inc. - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - octinoxate 1149 mg in 60.45 g - - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Соединенные Штаты - английский - NLM (National Library of Medicine)

shiseido america inc. - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - - helps prevent sunburn - higher spf gives more sunburn protection - retains spf after 40 minutes of perspiring

Соединенные Штаты - английский - NLM (National Library of Medicine)

shiseido america inc. - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - - helps prevent sunburn - higher spf gives more sunburn protection - retains spf after 40 minutes of perspiring

Соединенные Штаты - английский - NLM (National Library of Medicine)

shiseido america inc. - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Соединенные Штаты - английский - NLM (National Library of Medicine)

hainan poly pharm. co., ltd. - sodium nitroprusside (unii: eao03pe1tc) (nitroprusside - unii:169d1260km) - sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. sodium nitroprusside indicated for induction and maintenance of controlled hypotension in adults and children during surgery, to reduce bleeding. sodium nitroprusside is indicated for the treatment of acute heart failure to reduce, left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure. - diseases with compensatory hypertension (e.g., coarctation of the aorta, arteriovenous shunting). - inadequate cerebral circulation or in moribund patients (a.s.a. class 5e) coming to emergency surgery. - patients with congenital (leber’s) optic atrophy or with tobacco amblyopia.   - acute heart failure associated with reduced peripheral vascular resistance. - concomitant use with sildenafil, tadalafil, vardenifil, or riociguat.  risk summary based on animal data and mechanism of action, sodium nitroprussid

Соединенные Штаты - английский - NLM (National Library of Medicine)

slate run pharmaceuticals, llc - sodium nitroprusside (unii: eao03pe1tc) (nitroprusside - unii:169d1260km) - sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. sodium nitroprusside indicated for induction and maintenance of controlled hypotension in adults and children during surgery, to reduce bleeding. sodium nitroprusside is indicated for the treatment of acute heart failure to reduce left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure. - diseases with compensatory hypertension (e.g., coarctation of the aorta, arteriovenous shunting). - inadequate cerebral circulation or in moribund patients (a.s.a. class 5e) coming to emergency surgery. - patients with congenital (leber’s) optic atrophy or with tobacco amblyopia. - acute heart failure associated with reduced peripheral vascular resistance. - concomitant use with sildenafil, tadalafil, vardenafil, or riociguat. based on animal data and mechanism of action, sodium nitroprusside may lead to cya